当前位置:首页 - 行情中心 - 立方制药(003020) - 财务分析

立方制药

(003020)

  

流通市值:45.61亿  总市值:62.99亿
流通股本:1.38亿   总股本:1.90亿

立方制药(003020)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.92亿元,每股收益0.47元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益192241.24万元,未分配利润97339.96万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产254265.10万元,负债62023.86万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入732,436,475.72360,228,684.631,518,486,284.881,125,115,398.63
营业总成本660,113,516.51323,750,061.351,355,969,823.261,000,958,904.88
其他经营收益
营业利润101,024,033.6544,108,590.09177,734,668.99131,563,699.42
利润总额100,880,100.944,167,535.56171,815,971.97131,320,154.83
净利润91,530,260.0939,275,579.73152,480,813.62115,656,533.48
每股收益
其他综合收益----
综合收益总额91,530,260.0939,275,579.73152,480,813.62115,656,533.48
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,139,680,069.571,193,930,238.631,185,494,963.221,158,018,371.95
非流动资产:
非流动资产合计1,402,970,919.751,402,128,258.71,400,480,350.891,396,805,593.89
资产总计2,542,650,989.322,596,058,497.332,585,975,314.112,554,823,965.84
流动负债:
流动负债合计532,617,848.94557,260,557.59581,952,319.84537,803,723.7
非流动负债:
非流动负债合计87,620,719.6987,094,150.1191,424,387.8392,359,472.66
负债合计620,238,568.63644,354,707.7673,376,707.67630,163,196.36
所有者权益(或股东权益):
归属于母公司股东权益合计1,766,977,647.521,775,966,833.091,737,886,950.361,731,705,401.75
股东权益合计1,922,412,420.691,951,703,789.631,912,598,606.441,924,660,769.48
负债和股东权益合计2,542,650,989.322,596,058,497.332,585,975,314.112,554,823,965.84
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计920,724,302.84430,690,872.381,594,254,599.391,200,615,262.71
经营活动现金流出小计824,121,834.85394,629,659.071,396,721,856.621,073,938,500.05
经营活动产生的现金流量净额96,602,467.9936,061,213.31197,532,742.77126,676,762.66
投资活动产生的现金流量:
投资活动现金流入小计240,624,210.8357,919,754.72381,384,215.65281,061,137.75
投资活动现金流出小计397,079,814.8876,948,231.6563,618,850.83516,033,237.1
投资活动产生的现金流量净额-156,455,604.05-19,028,476.88-182,234,635.18-234,972,099.35
筹资活动产生的现金流量:
筹资活动现金流入小计86,4951,00029,815,754.329,117,727.92
筹资活动现金流出小计129,262,791.0842,439,717.4108,147,500103,752,671.06
筹资活动产生的现金流量净额-129,176,296.08-42,438,717.4-78,331,745.7-74,634,943.14
汇率变动对现金及现金等价物的影响-7,247-1,133.255,484.88-8,840.68
现金及现金等价物净增加额-189,036,679.14-25,407,114.22-63,028,153.23-182,939,120.51
期末现金及现金等价物余额250,657,380.45411,484,493.62439,694,059.59319,783,092.31
补充资料:
现金及现金等价物的净增加额-189,036,679.14--63,028,153.23-
最新报告期:2025-08-27
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
山西证券魏赟1.041.351.792025-08-27
山西证券魏赟1.111.471.942025-05-30
TOP↑